GTC
NUVB icon

Ghost Tree Capital’s Nuvation Bio NUVB Stock Holding History

Ghost Tree Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.09M Buy
1,350,000
+200,000
+17% +$610K 0.93% 38
2024
Q2 		$3.36M Buy
+1,150,000
New +$3.51M 1.05% 37
2021
Q2 		– Sell
-500,000
Closed -$4.96M – 63
2021
Q1 		$4.96M Buy
+500,000
New +$5.59M 1.17% 32

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Ghost Tree Capital's NUVB Position: Q3 2024 in Review

Ghost Tree Capital increased its Nuvation Bio (NUVB) stake by 17% in Q3 2024, buying an estimated $610K and bringing the position to 1,350,000 shares worth $3.09M. The position accounts for 0.93% of the portfolio, ranked #38.

Ghost Tree Capital first reported a position in NUVB in Q1 2021 and has held it in 3 quarters since. The position peaked at $4.96M in Q1 2021. 154 funds tracked by Wall St. Rank hold NUVB as of Q3 2024.

  • Ghost Tree Capital held 1,350,000 shares of Nuvation Bio worth $3.09M as of Q3 2024.
  • Ghost Tree Capital bought 200,000 Nuvation Bio shares in Q3 2024, an estimated $610K.
  • Nuvation Bio made up 0.93% of Ghost Tree Capital's portfolio in Q3 2024, its #38 holding.
  • Ghost Tree Capital first reported a position in Nuvation Bio in Q1 2021 and has held it in 3 quarters since.
  • Ghost Tree Capital's Nuvation Bio position peaked at $4.96M in Q1 2021.
  • 154 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.